HOXD10 and central nervous system cancer: Furthermore, RT-qPCR and Western blot analysis revealed that the enhanced transfection with HOXD10 siRNAs resulted in a decrease in both ASCL4 mRNA and protein expression in glioma cells (Figure 4G,H).